Analysts Are Bullish on Top Healthcare Stocks: Neurogene (NGNE), Cogent Biosciences (COGT)
Elevate Your Investing Strategy:
Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Neurogene (NGNE)
Stifel Nicolaus analyst Paul Matteis maintained a Buy rating on Neurogene on July 7 and set a price target of $46.00. The company's shares closed last Friday at $21.43, close to its 52-week low of $13.47.
According to TipRanks.com, Matteis is a 3-star analyst with an average return of 2.8% and a 43.2% success rate. Matteis covers the Healthcare sector, focusing on stocks such as Sionna Therapeutics, Inc., KalVista Pharmaceuticals, and BioMarin Pharmaceutical.
Currently, the analyst consensus on Neurogene is a Strong Buy with an average price target of $38.20, implying a 76.5% upside from current levels. In a report issued on June 30, BMO Capital also maintained a Buy rating on the stock with a $26.00 price target.
Cogent Biosciences (COGT)
In a report released today, Sam Slutsky from LifeSci Capital maintained a Buy rating on Cogent Biosciences, with a price target of $20.00. The company's shares closed last Friday at $10.98.
According to TipRanks.com, Slutsky has currently 0 stars on a ranking scale of 0-5 stars, with an average return of -2.6% and a 38.8% success rate. Slutsky covers the Healthcare sector, focusing on stocks such as DBV Technologies SA – American, Abivax SA Sponsored ADR, and Olema Pharmaceuticals.
Cogent Biosciences has an analyst consensus of Strong Buy, with a price target consensus of $18.64, a 74.7% upside from current levels. In a report issued on June 30, Citi also maintained a Buy rating on the stock with a $15.00 price target.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Axios
13 minutes ago
- Axios
House "crypto week" could change how Americans use, save money
A few years ago crypto was mostly a pariah in the financial services industry. Now, at the urging of the "first crypto president," Congress is on the verge of remaking American finance to embrace it. Why it matters: "Crypto week" could change everything from how Americans make payments to how they invest. It would also grant further legitimacy to an industry that has made the president and his family sudden billions of dollars. State of play: House Republicans declared the next five days Crypto Week, sending a clear message on legislative priorities after passing President Trump's "big, beautiful bill." The agenda for next week consists of three bills. One is stablecoin legislation, and sources familiar with the plans tell Axios that the Senate-passed bill, known as the GENIUS Act, will get a straight-up vote next week. Stablecoins are how dollars go on blockchains, and they enable super-fast, super-cheap global payments. They started as liquidity for crypto traders, but now companies use them for global payroll. The bill would establish rules for who could issue stablecoins and how they manage them. It is expected to lead to a surge of new products and participation from traditional finance firms. How it works: The legislation would "spur more comfort among retailers and others to begin accepting stablecoins as payment," says Tony Tuths, tax principal in KPMG's alternative investment tax practice. Financial markets, meanwhile, could start to move funds in stablecoins — as opposed to cash — for faster settlements with less cost, he added. That could profoundly change how payments are made and processed in the U.S., putting pressure on traditional payment networks like Visa and Mastercard. Market structure legislation is the other big one the table. It would create a framework for regulating broader crypto issuance and trading. If passed — the Senate is currently drafting its own version — it would establish a new category of registered digital assets, flashing a green light for traditional finance. More crypto related products would be expected to enter the mainstream market through retail brokerage accounts, Tuths says, "thereby opening a floodgate of retail capital into the crypto trading ecosystem." The third bill slated for this week is to prevent the Fed from ever creating a digital version of official U.S. currency, or a central bank digital currency (CBDC). Conservatives oppose the concept because they think it would mean more government intrusion into peoples' private lives. What they're saying: "It's one of these industries that, for a very, very, very long time has sought legitimization, either through getting these activities regulated at higher levels around the world, or through, of course, proving their real world use cases," Dante Disparte, head of global policy for stablecoin issuer Circle, tells Axios. Zoom out: So why now? For lawmakers, pressure to move is coming from a couple of different places — the president promising to deliver wins for the industry, plus a trio of linked PACs with more than $100 million on hand keeping tabs on how lawmakers vote. It's a whole different world from when the nation's leading crypto company, Coinbase, requested rule making and got sued by the Biden administration instead. Friction point: Several Democrats will be pushing back next week. Maxine Waters (D-Calif.), the top Dem on the House Financial Services Committee, is calling next week"Anti-Crypto Corruption Week," calling all three bills "dangerous pieces of crypto legislation." At the center of many Democrats' resistance is President Trump himself, due to his family's considerable personal investments in cryptocurrency putting a the specter of corruption risks over the process. The bottom line: Republican leadership is likely to relish these votes, because they know 90% of their members will fall in line.
New York Times
4 hours ago
- New York Times
So Your Doctor Is a DO. Does That Matter?
By most measures, osteopathic medicine is a profession in its prime. The number of doctors of osteopathic medicine, or D.O.s, has grown 70 percent in the last decade and is expected to continue expanding. More than a quarter of all medical students in the United States are training to become D.O.s, thanks in part to limited slots in traditional medical schools and ever-growing openings at osteopathic schools (14 campuses have opened in the last five years). And in recent years, the field has gained prestige as its doctors have risen to the highest medical posts in the country: leading top medical systems, overseeing NASA's medical team, running the most followed medical page on social media and, during the last three administrations, overseeing the medical care of the president of the United States. 'I do think we are — I don't want to say infiltrating — but we are everywhere,' said Dr. Teresa A. Hubka, the president of the American Osteopathic Association. Yet the changing face of medicine has largely been invisible to the public. Beyond vague notions that D.O.s are more holistic, or stereotypes that they were rejected from traditional medical schools, very few patients know how a D.O.'s training might shape their health care. One of the most commonly searched questions on Google about D.O.s, who have had full rights to practice medicine in the United States since 1973, is whether they are physicians. Over the course of Dr. Christina Weaver's career as an osteopathic doctor, she has been mistaken for a 'bone doctor' (orthopedist), a homeopath (an alternative healer with no medical degree) and a chiropractor (also no medical degree). Want all of The Times? Subscribe.
Newsweek
4 hours ago
- Newsweek
Biden's Legacy: What Remains After Trump Dismantled Build Back Better?
Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources. Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content. Presidents are often remembered for the policies they champion and the battles they fight—both militarily abroad and culturally at home. Yet, as the Oval Office swings from party to party, the core pieces of one administration's legacy often become the first targets of the next, dismantled or remade in favor of a new mandate. Former President Joe Biden's time in office was a rare chapter in modern American politics, serving one term sandwiched between two led by President Donald Trump. Republican strategist John Feehery, partner at EFB Advocacy, described Biden to Newsweek as a "transitional figure" between two Trump presidencies. Where some presidents build and refine what came before, others work to tear down and reassemble the frameworks of their predecessors, often reshaping the nation's priorities in the process. The passage of Trump's sweeping domestic policy package, the One Big Beautiful Bill Act (OBBB), incorporates numerous provisions that undo Biden's Build Back Better Act agenda and presidential platform. As Trump's vision takes shape, Newsweek spoke with several politicos and professors about what this means for Biden's legacy and how it may impact the policy landscape both leaders have fought to define. Newsweek on Friday filled out an online contact form in seeking comment from Biden. Photo-illustration by Newsweek/Getty/Canva Biden's Build Back Better Act Legacy Biden, who pledged to "rebuild the backbone of the country," which he identified as the middle class, crafted a centerpiece bill focused on social spending and climate programs, which totaled around $1.75 trillion. The Democrat-led House passed the bill in 2021, but it was not voted upon in the Senate. However, portions of it were enacted piecemeal through other individual legislations and were a part of his larger political platform. At the time, the Congressional Budget Office (CBO) projected the Build Back Better Act would increase the deficit by $367 billion over a decade. However, based on the CBO data, the passage of the legislation would create an increase in tax revenue of $127 billion. The majority of the new revenue was due to taxes on the extremely wealthy due to tightening IRS restrictions. The bill allocated $555 billion toward clean energy and green initiatives, including funding wind and solar energy projects, as well as providing electric vehicle tax credits, among others. Fiscally, the bill aimed to provide 39 million households tax cuts up to $3,600 by expanding the Child Tax Credit. It also dedicated $400 billion to addressing child care costs and prekindergarten. The bill pushed to expand health care access, reducing premiums and closing the Medicaid Coverage Gap, supporting around 4 million uninsured people to obtain coverage even if living in states that did not expand Medicaid under the Affordable Care Act. Beyond his legislative ambitions, Biden presided over a nation grappling with the aftermath of a pandemic and the eruption of geopolitical crises. COVID-19 continued to shape American life and economic recovery efforts during his initial months as president, while across the world, Russia invaded Ukraine and Israel and Hamas broke out into war. Both mass conflicts have carried into the current administration. Feehery emphasized this, telling Newsweek that Biden "will be seen as presiding over some of the worst public policy positions in our nation's history, namely the Covid nightmare and the Russian invasion of Ukraine." However, George C. Edwards III, professor of political science at Texas A&M, views Biden's legacy through a different lens, telling Newsweek, "When the dust has settled, Joe Biden will be remembered for leading the U.S. out of the Covid-19 epidemic and helping the U.S. economy achieve a soft landing as the envy of the world." Edwards continued, "He also made historic strides in building the infrastructure of the country, advancing environmental protection, fighting climate change, developing renewable energy, and investing in digital technology." Biden's Infrastructure Investment and Jobs Act passed both the House and Senate and was signed into law in November 2021. He also championed the CHIPS and Science Act, which was signed into law in August 2022 and allocates $52.7 billion for semiconductor research, manufacturing and workforce development in the U.S. The act may mark one of the rare instances of Trump actually reinforcing a Biden-era policy, through the president's push to increase domestic manufacturing and levy steep tariffs. Barbara Perry, presidential studies professor at the University of Virginia's Miller Center, told Newsweek: "In the short run, President Biden's legacy seems upended by the OBBB and other reversals by the second Trump administration. In the long lens of history, however, he will be remembered for righting the ship of state, listing badly after January 6, 2021's attack on the Capitol, and saving Americans and the US economy from the ravages of the COVID-19 pandemic." She added that "Unfortunately for the near-term, because of his advanced age and health status, he will not be given the decades that Presidents Carter, Bush I, and Bush II had to boost their approval ratings in active post-presidencies." Trump's One Big Beautiful Bill Impact On Independence Day, Trump signed into law his "big, beautiful bill," likely to be considered the legislative legacy of his second term. The massive spending bill includes several provisions that essentially reverse large portions of Biden's policy initiatives, including massive cuts to Medicaid, elimination of electric vehicle and clean energy tax credits, tax cuts for high-income earners and corporations, and increased border security spending, education policy rollbacks, among others. Medicaid provides health coverage to tens of millions of low-income Americans, with around 71 million currently enrolled in the program. The CBO estimates that more than 10 million Americans could lose their health coverage under the law, and also anticipates the bill to slash the program by about $790 billion over the next decade to help offset roughly $4.5 trillion in tax breaks. "The effects of Trump's bill are so far-reaching that it's not just Biden's legacy that's at stake but FDR's, Truman's, Eisenhower's, JFK's, and, maybe above all, LBJ's," Sean Wilentz, professor of American history at Princeton University, told Newsweek in an email, pointing to the "effective destruction" of federal medical programs. Edwards said that while "Donald Trump is trying to reverse Biden's policies regarding climate change and renewable energy," it will be trying, as "the foundations have been laid." Conversely, Republican strategist Matt Klink told Newsweek that "Donald Trump is effectively erasing many of the Biden administration's most notable and public achievements," through the passage of his sweeping spending bill. He argues the bill has three central premises: "First, it reinforces long-time Republican priorities about the social safety net being there for people when needed, not a permanent government handout." "Second, for Donald Trump's [Make America Great Again] MAGA supporters, it provides funding to deliver on the president's campaign promises such as the border wall, more aggressive immigration enforcement, and a defense build-up." And lastly, according to Klink, "it negatively impacts the Biden-Harris legacy and has thrown national Democrats for a loop." He concluded, "President Biden, previously viewed as a moderate, was either misled or wasn't capable of stopping a radical leftward plunge by national Democrats. The center-right American electorate reacted negatively toward Joe Biden, Kamala Harris, and Congressional Democrats." As Republicans and Democrats gear up for the pivotal 2026 midterms—a referendum on Trump's tenure as much as a battle for Congress—the Democratic Party is taking a hard look at Biden's legacy and the fallout from the 2024 election. With control of the House and Senate at stake, they're racing to rebrand, regroup and mobilize their bases for the fight ahead. For Trump, his "big, beautiful bill" may soon stand as the cornerstone of his legacy, as its sweeping provisions take effect, dismantling significant portions of Biden's policy achievements and reshaping the nation's economic and social landscape.
